(Q35099754)

6 August 2017

1 reference

title

Avoiding steroids in solid organ transplantation (English)

1 reference

6 August 2017

main subject

organ transplantation

1 reference

Jan P Lerut

1

1 reference

6 August 2017

publication date

2 April 2003

1 reference

6 August 2017

published in

Transplant International

1 reference

6 August 2017

volume

16

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

213-224

1 reference

Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Hyperlipidemia in solid organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Treatment of osteopenia and osteoporosis after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Pediatric renal transplantation without steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Sirolimus permits steroid withdrawal from a cyclosporine regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Steroid withdrawal in liver transplantation: benefits, risks, and unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Effect of immunosuppressive and antiviral agents on hepatitis B virus replicationin vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Weaning of immunosuppression in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Update of current immunosuppressive drugs used in clinical organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

From first principles--tubulitis in protocol biopsies and learning from history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

A prospective, randomized, open-label study of steroid withdrawal in pancreas transplantation-a preliminary report with 6-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Long-term follow-up of pediatric cardiac transplant recipients on a steroid-free regime: the role of endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Withdrawal of immunosuppression in liver allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Steroid-free immunosuppression: balancing efficacy and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

Weaning of immunosuppression in living donor liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00291.X

10.1111/J.1432-2277.2003.TB00291.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference